View full meeting coverage »

Eyetube Meeting Coverage:

2017 American Academy of Ophthalmology

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

DME Outcomes Following TREX

David Brown, MD, provides an overview of the 2-year outcomes of the TREX diabetic macular edema (DME) trial. Dr. Brown describes the three participating cohort groups in the trial of 150 eyes, with 30 eyes treated with monthly anti-VEGF injections for 2 years, 60 eyes treated with four ranibizumab injections (Lucentis, Genentech) and guided laser, and the remaining 60 eyes treated with four ranibizumab injections without guided laser. So far, the study has demonstrated that, with maintenance and a treat-and-extend regimen, visual acuity gains can be achieved both with and without guided laser.

Genentech • Lucentis • TREX


3 / 26 Series: 2017 American Academy of Ophthalmology


More Videos in this Series


View full meeting coverage (26 videos)
This program is not affiliated with the official program of AAO 2017.